News
Article
Author(s):
In case you missed it, this week we had news about skin cancer resources to share with patients, positive phase 3 results of imsidolimab for GPP, improvement in anxiety and depression after 2 years of treatment with dupilumab for AD, and more.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
Click here to read more and answer our quiz questions in recognition of Skin Cancer Awareness Month and Melanoma Monday.
The Harris brothers serve 2 predominantly elderly populations and appreciate the opportunity to provide solutions for the growing complexity of skin cancer issues as patients live longer.
Dozens of investigators shared findings to advance care in patients with melanoma during Mohs micrographic surgery.
Researchers found that the diameter of cutaneous melanoma demonstrated a weak positive correlation with tumor thickness.
Marc Hurlbert, PhD, discusses how the Melanoma Research Alliance works with dermatology clinicians to provide funding and resources for melanoma research.
Brian Kim, MD, had an unexpected attendee at one of his AAD sessions and delves into what's new, what's now, and what's next in atopic dermatitis management.
In addition, authors of a research letter noted that patients with vitiligo demonstrated a comparable risk of myocardial infarction and cerebrovascular accident.
ASLAN Pharmaceuticals presented new data this morning, including a 90% EASI score reduction.
A 5-expert panel delves into atopic dermatitis guidelines and recommendations and recent studies to make note of.
Dermatology Times' Spring Editor in Chief, Aaron Farberg, MD, discusses the business strategy known as buy and bill.
Following treatment, 17.5% and 13% of patients reported residual depressive and anxiety symptoms.
Aaron Farberg, MD, discusses the low-dose, affordable Accutane treatment and Clear Health’s mission to improve patient access to affordable acne therapies.
The awarded grant will span a total of 3 years.
Topical Bacitracin, Neosporin, and Vaseline were applied to mice over a 6-week period.
A prebiotic cleanser and moisturizer regimen not only significantly alleviated the severity of atopic dermatitis and xerosis, but also uncovered crucial differences in symptom experiences.
Renata Block, MMS, PA-C, shares her favorite topics from the aesthetic conference held last month.
Leading dermatologists explore key benchmarks, emerging trends, personalized medicine approaches, and more in atopic dermatitis.
Authors of a recent review concluded that combining various therapies holds promise in the treatment of acne scarring.
VYNE expects to enroll the first patient with vitiligo in the phase 2b trial for VYN201 in the second quarter of 2024.
Researchers explored the risk of SPM in patients of different races with the rare type of tumor of the skin.
This Skin Cancer Awareness Month, we have compiled a list of resources for clinicians to share with their patients.
Patients who responded to imsidolimab in GEMINI-1 and who moved into GEMINI-2 maintained clear or almost clear skin.
A poster from the 2024 American Psychiatric Association Annual Meeting delved into the relationship between MDD and various dermatologic conditions.
Patients with AD experienced significant impacts to disease severity, disease control, and quality of life regardless of lesion location count.
Factors such as ultraviolet radiation, rising temperature, and air pollution may all play a role in the increasing incidence of skin cancers.
Earlier this week, we shared our first Skin Cancer Awareness Month quiz. Review the answers and your responses below.